Navigation Links
Anthera Presents Data on Varespladib at ATVB Meeting
Date:4/17/2008

ogi & Co. Ltd. worldwide rights (excluding Japan) to a series of clinical and pre-clinical compounds that inhibit the enzymatic activity of members of the phospholipase (PLA2) family -- a group of enzymes responsible for the release of arachidonic acid and subsequent production of leukotrienes prostacyclins and other mediators of inflammation. These highly potent compounds inhibit novel upstream steps in the inflammation cascade and have the potential to address a variety of diseases. The company has also acquired exclusive and worldwide rights to a peptide fusion protein, A-623, for the treatment of systemic lupus erythematosus (SLE) and other autoimmune diseases from Amgen. For more information, please visit http://www.anthera.com

INVESTOR AND MEDIA CONTACT:

Anne Bowdidge

(650) 218-6900

pr@anthera.com


'/>"/>
SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Anthera Pharmaceuticals Forms Scientific Advisory Board
2. European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreichs Ataxia by Santhera
3. Telik Presents Preclinical Data at 99th Annual Meeting of the American Association for Cancer Research
4. ProMetic presents preclinical data for prostate and pancreatic cancer at the AACR Meeting
5. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect
6. Kosan Presents Preclinical Data on Novel Third-Generation Hsp90 Inhibitors at AACR
7. Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040
8. SGX Presents Preclinical MET Data at AACR
9. ARIUS presents new findings for anti-cancer antibody programs at AACR
10. Ardea Presents Preclinical Data on Novel Next Generation Non-Nucleoside Reverse Transcriptase Inhibitors Demonstrating Potent Anti-HIV Activity Against Resistant Viruses
11. MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... December 15 , ... to Evaluate the Ability of,Cardiopoietic Cells to Restore ... BioSciences, a leading Belgian biotechnology company specialising,in cell-based ... that it has completed, two months ahead of ... Phase II/III trial of C-Cure, a,unique stem cell ...
(Date:12/14/2009)... Calif., Dec. 14 Array BioPharma Inc. ... AMGN ) today announced that they entered into ... Array,s small-molecule glucokinase activator program, including ARRY-403, currently ... in patients with Type 2 diabetes. ... will receive an upfront payment of $60 million ...
(Date:12/14/2009)... Dec. 14 Dyadic International, Inc. (Pink ... extended its collaboration with The Scripps Research Institute ... to re-annotate the genome of Dyadic,s patented and ... a continuation of the successful relationship between the ... Dyadic engaged Scripps to annotate the C1 genome ...
(Date:12/14/2009)... ROCKAWAY, N.J., Dec. 14 The third ... Approach , published by the ... FDA-approved treatment for anthracycline extravasation.(1) Anthracyclines are ... idarubicin and epirubicin that have been used in ... the early 1970s.(2) ,, According to ...
Breaking Biology Technology:Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5
... 4 deCODE genetics,(Nasdaq: DCGN ) today announced ... Kari Stefansson,s presentation at the JPMorgan 26th Annual Healthcare,Conference., ... PST / 7:30 pm GMT on,Thursday, January 10 at ... be accessed through the Investors page on deCODE,s website, ...
... - VELCADE(R) (bortezomib) for Injection sales grew 20% to $265 million in ... ... front-line multiple myeloma -,- MLN0002 core bridging studies fully enrolled, showing favorable results ... - On track to exceed 2007 net income ...
... AutoGenomics announced today,that the Company has been invited and ... is being held January 7-10, 2008 at,the Westin St. ... Kureshy President and Chief Executive Officer will provide an,overview ... 8, 2008., About JPMorgan 26th Annual Healthcare Conference, ...
Other Biology Technology:Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 2Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 3Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 4Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 5Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 6Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 7Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 8Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 9
(Date:12/13/2009)... have identified plant enzymes that may help to engineer ... use water more efficiently. The finding could help to ... , Plants take in the carbon dioxide they need ... of leaves. But for each molecule of the gas ... same openings. The pores can tighten to save water ...
(Date:12/13/2009)... have discovered five genetic variants that are associated with ... an international consortium of 96 scientists from 63 centres ... molecular basis of lung diseases. , The new findings ... Chronic Obstructive Pulmonary Disease (COPD) and asthma. In the ... because the molecular pathways that affect the health of ...
(Date:12/11/2009)... for premium fruit increases, growers are being challenged ... to boost their bottom line, orchard owners are ... quality while reducing labor costs. , Hand thinning, ... larger, healthier fruit, is among the most labor-intensive ... fruit production overhead, and, ultimately, prices paid by ...
Breaking Biology News(10 mins):Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3New genes for lung disease discovered 2Horizontal string trimmer reduces labor costs, increases peach size 2SunGard Availability Services Addresses the Business Operational and Workforce Issues Involved in Pandemic Planning 60100 1SunGard Availability Services Addresses the Business Operational and Workforce Issues Involved in Pandemic Planning 60100 2SunGard Availability Services Addresses the Business Operational and Workforce Issues Involved in Pandemic Planning 60100 3SunGard Availability Services Addresses the Business Operational and Workforce Issues Involved in Pandemic Planning 60100 4LABS Inc to Offer Donor Testing Services for Transfusion Medicine and Blood Services Industry 60097 1LABS Inc to Offer Donor Testing Services for Transfusion Medicine and Blood Services Industry 60097 2Morpace Reports 3A H1N1 Flu Could Adversely Impact Holiday Shopping Season 60094 1Morpace Reports 3A H1N1 Flu Could Adversely Impact Holiday Shopping Season 60094 2
... the Montreal Neurological Institute of McGill University and the ... Music and Sound Research (BRAMS), has found that tone-deaf ... regions of the brain related to processing musical pitch, ... auditory cortex, as compared to those who are musically ...
... 19, 2007) -- Approximately one in every 500 to 650 ... variation in their genetic code that until a few years ... However, this is no longer the case. A recent conference ... KS&A focused on raising awareness of the condition and the ...
... squirrels chew up rattlesnake skin and smear it on ... to a new study by researchers at UC Davis. ... at UC Davis, observed ground squirrels (Spermophilus beecheyi) and ... by picking up pieces of shed snakeskin, chewing it ...
Other Biology News:Jingle bells not merry for tone-deaf individuals 2Jingle bells not merry for tone-deaf individuals 3Physician-scientists seek solutions to reproductive problems related to chromosomal variations 2Physician-scientists seek solutions to reproductive problems related to chromosomal variations 3
Anti 4-hydroxy-2-hexenal (4-HHE) Monoclonal Antibody (HNEJ-2)...
... signals in immunostaining ,This solution has effect ... to get clearer signal than the one ... the amount of secondary antibody used and ... you can have images with high S/N ...
Anti-human VEGFR-2/KDR (Protein-A Purified) Polyclonal Antibody...
... tissues this enzyme exists predominantly as XDH ... acid, a critical plasma antioxidant. During ... oxygen radical producing XO by oxidation of ... proteolytic cleavage of the amino-terminus. AO ...
Biology Products: